Inappropriate prescription of proton pump inhibitors on two pulmonary medicine wards

European Journal of Gastroenterology and Hepatology

Volumn 20, Issue 7, 2008, Pages 608-612

  Vliet, Evelyn P M Van ^a   Otten, Henk J A M ^a   Rudolphus, Arjan ^b   Knoester, Pieter D ^a   Hoogsteden, Henk C ^a   Kuipers, Ernst J ^a   Siersema, Peter D ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Sint Franciscus Gasthuis ^*  (Netherlands)

Author keywords

Indications; Overuse; Proton pump inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; DRUG INDICATION; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH CENTER; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PEPTIC ULCER; POSTMARKETING SURVEILLANCE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STOMACH HEMORRHAGE; STOMACH PERFORATION; STOMACH ULCER; TREATMENT WITHDRAWAL; UNIVERSITY HOSPITAL; WARD; CLINICAL TRIAL; DRUG USE; DRUG UTILIZATION; HEALTH SERVICE; MIDDLE AGED; MULTICENTER STUDY; PRACTICE GUIDELINE; PULMONOLOGY; STANDARD; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; DRUG PRESCRIPTIONS; DRUG UTILIZATION; DRUG UTILIZATION REVIEW; FEMALE; GUIDELINE ADHERENCE; HEALTH SERVICES MISUSE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; PULMONARY MEDICINE;

EID: 57649232534     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282f52f95     Document Type: Article

References (16)

1. Walker NM, McDonald J. An evaluation of the use of proton pump inhibitors. Pharm World Sci 2001; 23:116-117.
2. Richtlijn NSAID -gebruik en preventie van maagschade. Kwaliteitsinstituut voor de Gezondheidszorg CBO-Utrecht, 2003.
3. Richtlijn Maagklachten. Kwaliteitsinstituut voor de Gezondheidszorg CBO - Utrecht, 2004.
4. Kuipers EJ, Meuwissen SG. The efficacy and safety of long-term omeprazole treatment for gastroesophageal reflux disease. Gastroenterology 2000; 118:795-798.
5. Lanas A, Ferrandez A. Inappropriate prevention of NSAID-induced gastrointestinal events among long-term users in the elderly. Drugs Aging 2007; 24:121-131.
6. Batuwitage BT, Kingham JG, Morgan NE, Bartlett RL. Inappropriate prescribing of proton pump inhibitors in primary care. Postgrad Med J 2007; 83:66-68.
7. Murthy SK, Kauldher S, Targownik LE. Physicians' approaches to the use of gastroprotective strategies in low-risk non-steroidal anti-inflammatory drug users. Aliment Pharmacol Ther 2006; 23:1365-1372.
8. Van Soest EM, Siersema PD, Dieleman JP, Sturkenboom MC, Kuipers EJ. Persistence and adherence to proton pump inhibitors in daily clinical practice. Aliment Pharmacol Ther 2006; 24:377-385.
9. Richardson P, Hawkey CJ, Stack WA. Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders. Drugs 1998; 56:307-335.
10. Triadafilopoulos G. Proton pump inhibitors for Barrett's oesophagus. Gut 2000; 46:144-146.
11. Vanderhoff BT, Tahboub RM. Proton pump inhibitors: an update. Am Fam Physician 2002; 66:273-280.
12. Numans ME, De Wit NJ, Dirven JAM, Hurenkamp GJB, Meijer QCM, Muris JWM. NHG standaard Maagklachten (tweede herziening). Huisarts Wet 2003; 46:690-700.
13. Dubois RW, Melmed GY, Henning JM, Laine L. Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy. Aliment Pharmacol Ther 2004; 19:197-208.
14. Chan FK, Graham DY. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications-review and recommendations based on risk assessment. Aliment Pharmacol Ther 2004; 19:1051-1061.
15. Zullo A, Hassan C, Campo SM, Morini S. Bleeding peptic ulcer in the elderly: risk factors and prevention strategies. Drugs Aging 2007; 24:815-828.
16. http://www.gipdatabank.nl [Accessed on 14 July 2007].